ombrabulin
Sign in to saveOmbrabulin was an experimental drug candidate discovered by Ajinomoto and further developed by Sanofi-Aventis. Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.
Wikidata facts
- Mass
- 402.179
Show 3 more facts
- chemical formula
- C₂₁H₂₆N₂O₆
- isomeric SMILES
- COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)NC(=O)[C@H](CO)N
- canonical SMILES
- COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)NC(=O)C(CO)N
Sources (2)
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
{{Chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 445300917 | ImageFile = Ombrabulin.svg | ImageClass = skin-invert-image | ImageSize = 200px | ImageAlt = | IUPACName = N1-{2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethen-1-yl]phenyl}-L-serinamide | SystematicName = (2S)-2-Amino-3-hydroxy-N-{2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethen-1-yl]phenyl}propanamide | OtherNames = AVE-8062; AVE-8062A; AC7700; CS-39-L-Ser.HCl |Section1= |Section2= |Section3= }}
Ombrabulin was an experimental drug candidate discovered by Ajinomoto and further developed by Sanofi-Aventis. Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.